Login / Signup

Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial.

Wendy S LaneElena FavaroEsteban JódarPranav KelkarAlejandra OviedoRamsathish SivarathinasamiPeter A SeniorGiorgio SestiEdward Franek
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
NCT03268005.
Keyphrases
  • type diabetes
  • phase iii
  • study protocol
  • phase ii
  • glycemic control
  • clinical trial
  • open label
  • metabolic syndrome
  • placebo controlled